DermWire | Newest Articles http://practicaldermatology.com/dermwire/ Newest Articles en-us Mon, 27 Feb 2017 12:41:45 GMT Mon, 27 Feb 2017 12:41:45 GMT DermWire DermMentors™ 2017 Resident of Distinction Award Honors Five Dermatology Residents http://practicaldermatology.com/dermwire/view.asp?url=dermmentors-2017-resident-of-distinction-award-honors-five-dermatology-residents As part of the dermMentors™ Resident of Distinction Award program, sponsored by Beiersdorf Inc., five dermatology residents attended the 16th Annual Caribbean Dermatology Symposium in Aruba, Netherlands Antilles, from January 17 - 21, 2017. The dermMentors™ Resident of Distinction awardees -- Sean Condon, MD, of the Cleveland Clinic, Brienne Cressey, MD, of New York-Presbyterian Weill Cornell Weill Cornell Medical College, Daniel Opel, MD, of Loyola University Chicago, Eric S… Thu, 23 Feb 2017 04:00:00 GMT Obagi Medical Products Collaborates with Suzan Obagi, MD and Nextcell Medical to Introduce New Line http://practicaldermatology.com/dermwire/view.asp?url=obagi-medical-products-collaborates-with-suzan-obagi-md-and-nextcell-medical-to-introduce-new-line Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary Obagi Medical Products collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD’s line of skin care products throughout the United States. Established in 2013 with cosmetic surgeon and dermatologist, Suzan Obagi, MD, Nextcell Medical has been working on innovations to change the industry’s approach to skin care. According to the company, Obagi intends to continue to inves… Thu, 23 Feb 2017 04:00:00 GMT Cloudy With a Chance of Wrinkles: Most Americans Fail to Protect Skin From Pollution http://practicaldermatology.com/dermwire/view.asp?url=cloudy-with-a-chance-of-wrinkles-most-americans-fail-to-protect-skin-from-pollution Most Americans don’t protect their skin from pollutants even though they are aware of the harm that pollution and other environmental stressors can cause to skin, according to a new survey by H2O+ Beauty. Just 33 percent of people purchase skincare products to protect their skin against pollution and other environmental stressors -- such as traffic and car exhaust, factories and power plants, and secondhand smoke -- even though a majority understand the risk of exposure to such chem… Wed, 22 Feb 2017 04:00:00 GMT Vision Medical’s SmartGraft Now Offers Articulating Arm With Mayo Tray http://practicaldermatology.com/dermwire/view.asp?url=vision-medicals-smartgraft-now-offers-articulating-arm-with-mayo-tray SmartGraft® Hair Restoration is rolling out its first articulating arm and mayo tray, Vision Medical Inc., reports. Available in February, the SmartGraft AMT (articulating mayo tray) provides ergonomic design for physicians Available to new systems as well as physicians who currently have the SmartGraft Hair Restoration System, Features include: Ergonomic design to help reduce procedure time and operator fatigue. Enhanced accessibility for efficiently utilizing smaller opera… Tue, 21 Feb 2017 04:00:00 GMT CareCredit to Acquire CitiHealth Card Portfolio http://practicaldermatology.com/dermwire/view.asp?url=carecredit CareCredit has signed an agreement with Citibank, N.A. to acquire the Citi Health Card portfolio, further expanding its healthcare acceptance network in the United States. The portfolio acquisition includes more than 14,500 providers, further expanding CareCredit’s national network of more than 200,000 healthcare providers and health-focused retail locations. The portfolio includes more than 110,000 current Citi Health Card consumer accounts. Terms of the agreement were not disclosed. … Tue, 21 Feb 2017 04:00:00 GMT Suzanne Olbricht, MD, Named New Chief of Dermatology at Beth Israel Deaconess Medical Center http://practicaldermatology.com/dermwire/view.asp?url=suzanne-olbricht-md-named-new-chief-of-dermatology-at-beth-israel-deaconess-medical-center Suzanne Olbricht, MD, is the new Chief of Dermatology at Beth Israel Deaconess Medical Center (BIDMC) in Boston. She will also serve as President of the American Academy of Dermatology in 2018. From 1983 to 1997, Dr. Olbricht worked as a staff dermatologist at what was then Beth Israel Hospital. She then served as Chair of the Dermatology Department at Lahey Hospital and Medical Center from 1998 to 2017 where she developed and directed the first formal fellowship program in the world to train… Mon, 20 Feb 2017 04:00:00 GMT Save The Dates: ASLMS to Host 37th Annual Conference In Early April 2017 http://practicaldermatology.com/dermwire/view.asp?url=save-the-dates-aslms-to-host-37th-annual-conference-in-early-april-2017 American Society for Laser Medicine and Surgery (ASLMS) 2017 will take place April 5 -- 9, 2017 in San Diego, Calif. New for 2017 is a special CME Session, Moving from the Lab to the Clinic, which will focus on the translation of technologies and concepts from the laboratory to evaluation and implementation in a clinical environment. Other ASLMS 2017 hot topics include: New techniques involving light to treat cancer and kill bacterial infections The picosecond revolution continue… Fri, 17 Feb 2017 04:00:00 GMT Deadline Extended for Medical Spa State of the Industry Statistical Study http://practicaldermatology.com/dermwire/view.asp?url=deadline-extended-for-medical-spa-state-of-the-industry-statistical-study The American Med Spa Association (AmSpa) has extended the deadline for the 2017 Medical Spa State of the Industry Report, administered by MarketData Enterprises and sponsored by Modern Aesthetics® magazine. The report -- the only up-to-date resource of its kind focusing specifically on medical spas in the United States -- will gather information about medical spa geographical and ownership data; medical aesthetic facility types; medical spa size and revenue averages; regulatory compliance, a… Thu, 16 Feb 2017 04:00:00 GMT Clarisonic Introduces the Smart Profile Uplift http://practicaldermatology.com/dermwire/view.asp?url=clarisonic-introduces-the-smart-profile-uplift Clarisonic is rolling out a new at-home device, the Smart Profile Uplift. This 2-in-1 skincare device combines Clarisonic's cleansing with a new firming massage head. In clinical testing performed by the company, 12 weeks of twice daily use of Smart Profile Uplift with a placebo cream (without anti-aging actives) showed visible improvement of 15 signs of aging, especially wrinkles, firmness and radiance. Smart Profile Uplift also boosts the absorption of daily skincare. The Smart Profi… Thu, 16 Feb 2017 04:00:00 GMT Researchers Discover New Antibiotic That May Fight MRSA http://practicaldermatology.com/dermwire/view.asp?url=researchers-discover-new-antibiotic-that-may-fight-mrsa Researchers at the University of East Anglia (UEA) and the John Innes Centre (JIC) have uncovered a new antibiotic that they say is potent against antibiotic-resistant ‘superbugs’ like methicillin resistant Staphylococcus aureus (MRSA). The researchers isolated the new member of the Streptomyces bacteria family from the African fungus-growing plant-ant Tetraponera penzigi. They have named the new species Streptomyces formicae and the antibiotics formicamycins, after the Latin formica… Thu, 16 Feb 2017 04:00:00 GMT FDA Approves Valeant's SILIQ For Moderate-To-Severe Plaque Psoriasis http://practicaldermatology.com/dermwire/view.asp?url=fda-approves-valeants-siliq-for-moderate-to-severe-plaque-psoriasis The FDA has approved the Biologics License Application (BLA) for Valeant Pharmaceutical's SILIQ (brodalumab) injection, for subcutaneous use, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis. SILIQ is indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. Valeant expects t… Thu, 16 Feb 2017 04:00:00 GMT No Biopsy Required? Non-Invasive Skin Cancer Test May Offer Quick Diagnosis http://practicaldermatology.com/dermwire/view.asp?url=no-biopsy-required-non-invasive-skin-cancer-test-may-offer-quick-diagnosis A new non-invasive imaging technique may accurately detect skin cancer without surgical biopsy. Multiphoton microscopy of mitochondria accurately identified melanomas and basal cell carcinomas by detecting abnormal clusters of mitochondria in both types of skin cancer, according to researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB). “The technology developed here has the potential to make the detection of skin cancers extremely rapid and fea… Wed, 15 Feb 2017 04:00:00 GMT New From Skinceuticals: H.A. Intensifier http://practicaldermatology.com/dermwire/view.asp?url=new-from-skinceuticals-ha-intensifier SkinCeuticals is rolling out their new H.A. Intensifier, a corrective hyaluronic acid serum. Key ingredients include 10% Proxylane, a proprietary ingredient, to support hyaluronic acid levels and help maintain the integrity of the skin's matrix, for improved firmness 2.0% Dipotassium Glycyrrhizate + 0.2% Purple Rice Extract, to help preserve hyaluronic acid content in skin Three types of hyaluronic acid -- full molecular weight, fragmented and encapsulated chains Testin… Wed, 15 Feb 2017 04:00:00 GMT Rumor Has It Syneron Is Next In Week of Surprising Aquisitions http://practicaldermatology.com/dermwire/view.asp?url=rumor-has-it-syneron-is-next-in-week-of-surprising-aquisitions Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners is looking to buy Syneron Medical for $350-$400 million. According to Israeli financial daily Calcalist, representatives from Apax met Syneron executives in Israel last week and the talks are being managed by Barclays. None of the companies have offered an official comment on the report. Syne… Tue, 14 Feb 2017 04:00:00 GMT Ray Canole is New Chief Commercial Officer at Revision Skincare http://practicaldermatology.com/dermwire/view.asp?url=ray-canole-is-new-chief-commercial-officer-at-revision-skincare Revision Skincare has announced the appointment of Ray Canole to the position of Chief Commercial Officer. He has over 15 years of business development and commercial related experience in dermatology-focused organizations and joins Revision from Renaissance Pharma, where he helped build one of the largest privately-held topical companies in the US. Prior to Renaissance, Mr. Canole held various leadership positions in business and corporate development at the Perrigo Company. His background… Tue, 14 Feb 2017 04:00:00 GMT Hologic to Acquire Cynosure http://practicaldermatology.com/dermwire/view.asp?url=hologic-to-acquire-cynosure Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash. The transaction, which has been approved unanimously by the boards of directors of both companies, would extend Hologic's scientific and commercial capabilities into one of the fastest-growing segments in medical tech… Tue, 14 Feb 2017 04:00:00 GMT New From Alastin Skincare: HydraTint ProMineral Broad Spectrum Sunscreen SPF 36 http://practicaldermatology.com/dermwire/view.asp?url=new-from-alastin-skincare-hydratint-promineral-broad-spectrum-sunscreen-spf-36 ALASTIN Skincare, Inc. is introducing HydraTint ProMineral Broad Spectrum Sunscreen SPF 36. The lightweight matte formula is oil-free, absorbs quickly and has a tint. It also comprises an air pollution shield to protect skin from environmental aggressors and free radicals. “With the launch of our HydraTint ProMineral Broad Spectrum Sunscreen SPF 36, we now have an elegant companion product designed to protect the skin rejuvenation that patients have achieved after using our skin care… Mon, 13 Feb 2017 04:00:00 GMT Intramuscular Flu Shots May Mitigate Staph Risk In AD Patients http://practicaldermatology.com/dermwire/view.asp?url=intramuscular-flu-shots-may-be-better-for-ad-patients Staphylococcus colonization of atopic dermatitis patients’ skin is associated with a weaker response to intradermal flu shots, according to a new study which suggests that intramuscular flu vaccines may be more effective in this group. The research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is being published online in the Journal of Allergy and Clinical Immunology. Researchers evaluated 202 patients with atopic de… Mon, 13 Feb 2017 04:00:00 GMT Allergan to Acquire ZELTIQ for $2.47 Billion http://practicaldermatology.com/dermwire/view.asp?url=allergan-to-acquire-zeltiq-for-247-billion Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary adjustments. The acquisition of ZELTIQ is immediately accretive and enhances Allergan's global medical aesthetics portfolio with the addition of ZELTIQ's flagship CoolSculpting® System, the sales leader in the fast-growing cash pay body contouring segment of medical aesthetics. The Co… Mon, 13 Feb 2017 04:00:00 GMT Cochrane Review: All Moisturizers Created Equally for Eczema http://practicaldermatology.com/dermwire/view.asp?url=cochrane-review-all-moisturizers-created-equally No one moisturizer is better than another when it comes to relieving the symptoms of eczema, according to a new Cochrane Review. Overall, most moisturizers show beneficial effects for eczema, work better with active treatment, prolong time to flare, and reduce the number of flares and amount of topical corticosteroids needed to achieve similar reductions in eczema severity. The researchers reviewed 77 studies (6603 participants, mean age: 18.6 years, mean duration: 6.7 weeks). Of these, a… Fri, 10 Feb 2017 04:00:00 GMT Crescita Therapeutics Announces Management and Board Changes http://practicaldermatology.com/dermwire/view.asp?url=crescita-therapeutics-announces-management-and-board-changes Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, introduced Ms. Muneerah Kanji, MBA, CPA, CA, Crescita's Corporate Controller, as Interim Chief Financial Officer replacing Mr. Mario Laflamme who has resigned for health-related family reasons. Crescita has commenced a formal search process for a new Chief Financial Officer. "Ms. Kanji brings a weal… Fri, 10 Feb 2017 04:00:00 GMT Alma Lasers' Accent Celebrates 10 Years with a New Campaign http://practicaldermatology.com/dermwire/view.asp?url=alma-lasers-accent-celebrates-10-years-with-a-new-campaign Accent Prime is celebrating a 10 year anniversary with a newly launched campaign. Alma Lasers released the first generation of the Accent branded platform in 2007, with the FDA approval, and technologically enhanced it throughout the past decade up to the newest addition to Alma Lasers' family of body contouring products: Accent Prime. This latest platform combines advanced innovations in ultrasound and Unipolar radio frequency technologies to deliver fast, effective, highly customized treat… Thu, 9 Feb 2017 04:00:00 GMT ZO Skin Health Introduces Oraser Cellulite Control Cream http://practicaldermatology.com/dermwire/view.asp?url=zo-skin-health-introduces-oraser-cellulite-control-cream ZO Skin Health's new Oraser Cellulite Control is formulated to offer instant firming effects, visibly improve the skin's texture, and reduce the appearance of cellulite. In addition to smoothing skin and diminishing the "orange peel" appearance, the crème also helps improve microcirculation, reduce skin contour, encourage the production of collagen for firmer skin, and restore hydration to support a healthy skin barrier function, according to the company. Oraser Cellu… Wed, 8 Feb 2017 04:00:00 GMT Study Finds Increased Incidence of SCC Among Patients Treated with Biologics for Psoriasis http://practicaldermatology.com/dermwire/view.asp?url=study-find-increased-incidence-of-scc-among-patients-treated-with-biologics-for-psoriasis A recent study published in the Journal of the American Academy of Dermatology sought to estimate the overall malignancy rate (excluding non-melanoma skin cancere [NMSC]) and NMSC rate among 5,889 patients with systemically treated psoriasis. The researchers identified a cohort of adult Kaiser Permanente Northern California health plan members with psoriasis diagnosed from 1998 to 2011 who were treated with at least one systemic antipsoriatic agent and categorized them into ever-biologic or n… Wed, 8 Feb 2017 04:00:00 GMT PuraCap: Video Available to Educate Families, Children http://practicaldermatology.com/dermwire/view.asp?url=puracap-video-available-to-educate-families-children A new video from PuraCap® Pharmaceutical explores the effects of childhood eczema and how parents and kids can find relief. As many as one out of every three kids suffers from this chronic skin condition. Beyond the constant itching, irritation and distraction caused by this silent skin disease, many children also endure bullying, teasing and a major hit to their self-esteem due to the inflamed, rough patches. When left untreated, eczema, which may begin during infancy, continues on into … Mon, 6 Feb 2017 04:00:00 GMT